Pathophysiology Core
病理生理学核心
基本信息
- 批准号:10686928
- 负责人:
- 金额:$ 17.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:Animal ModelAnimalsBlood VesselsCellsCollectionComplementComplement ActivationDataDiseaseFunctional disorderGenomicsGoalsHistologicHumanImageImmune TargetingImmune systemImmunofluorescence ImmunologicImmunohistochemistryInflammationInflammatoryInvestigationLabelLeadershipLesionLungMalignant NeoplasmsMass Spectrum AnalysisMediatingMessenger RNAMethodologyMethodsModelingMorphologyMusNewborn InfantPathologistPathologyPatternPhenotypePreparationProteinsProteomeProteomicsPulmonary HypertensionRNARattusResearch PersonnelResourcesRoleSamplingServicesStructureSystemTranslatingTranslationsexperienceexperimental studyhigh throughput analysishuman tissueimaging approachimmune imaginginflammatory markerinnovationlaser capture microdissectionmemberpulmonary vascular disorderpulmonary vascular remodelingtissue processingtranscriptomics
项目摘要
The primary objective of the Pathology and Imaging Core is to provide accurate phenotypic characterization of
pulmonary vascular remodeling, document activation of complement, assess inflammation, and isolate mRNA
and proteins, in diseased IPAH human lungs and relevant models of PH. To accomplish these goals, we will
perform 8 tasks based on specific methodologies, aimed at integrating high quality tissue processing,
immunohistochemistry, and stereology with high throughput imaging approaches and laser capture
microdissection for all 4 projects in this PPG.
Aim 1: To provide qualitative and quantitative assessment of pulmonary vascular remodeling in lungs
of humans, steers and newborn calves, rats, and mice in Projects 1-4. We propose 4 specific tasks to
support this specific aim, which include: planning of experiments (task 1), collection, processing, and
phenotyping experimental lungs (task 2), morphology and stereology of pulmonary vascular remodeling (task
4), and integration of morphological data with specific project goals and aims (task 8).
Aim 2: To determine expression patterns and abundance of candidate molecules investigated in
experimental lungs. We propose 5 specific tasks to support this specific aim, which include planning of
experiments (task 1), tissue processing (task 2), morphology and stereology (task 3), laser capture
microdissection (LCM; task 7), and integration of morphological data with project goals and aims (task 8).
Aim 3: Specific Aim 3: To obtain high quality mRNA and protein for transcriptomic and proteomic
studies from specific pulmonary vascular structures and lesions from animals manipulated in Projects
1-4. We propose 5 specific tasks to support this specific aim, which include planning of experiments (task 1),
tissue processing (task 2), LCM (task 7), and integration of morphological data with specific project goals and
aims (task 8).
Aim 4: To translate the key expression findings in Specific Aim 2 to human control and PAH lungs. We
propose six specific tasks to support the specific aim, which include planning of experiments (task1), tissue
processing (task 2), human tissue studies (task 3), morphology and stereology (task 4), LCM (task 7), and
integration of morphological data with specific project goals and aims (task 8).
Foremost in accomplishing these goals is the scientific expertise within the leadership of the core. The
Pathology and Imaging Core is led by of Drs. Rubin M. Tuder, an experimental and practicing pulmonary
pathologist with major expertise in pathology and pathobiology of pulmonary hypertension, with the support of
Dr. Raphe Nemenoff, an experienced investigator in the cancer field with expertise in multiprobe immune
imaging targeting the immune system and complement. The novelty of the Pathology and Imaging Core lies
on the unique resources, unmatched expertise, and overall experimental breadth, allowing for the integration
and human translation pertaining to all four projects.
病理学和成像核心的主要目标是提供准确的表型特征
肺血管重塑、记录补体的激活、评估炎症和分离mRNA
和蛋白质,在患病的IPAH人肺和相关的PH模型中。为了实现这些目标,我们将
根据具体方法执行8项任务,旨在整合高质量的组织处理,
免疫组织化学、高通量成像方法和激光捕获的体视学
这个PPG中所有4个项目的显微解剖。
目的1:为肺血管重构提供定性和定量的评价
项目1-4中的人类、公牛和新生小牛、大鼠和小鼠。我们提出了4项具体任务
支持这一具体目标,其中包括:计划实验(任务1)、收集、处理和
实验肺表型(任务2)、肺血管重构的形态和体视学(任务2)
4),并将形态数据与具体的项目目标和目的相结合(任务8)。
目标2:确定研究的候选分子的表达模式和丰度
实验性肺。我们提出了5项具体任务来支持这一具体目标,其中包括规划
实验(任务1)、组织处理(任务2)、形态和体视学(任务3)、激光捕获
显微解剖(LCM;任务7);形态数据与项目目标和目的的整合(任务8)。
目标3:特定目标3:为转录和蛋白质组学获得高质量的mRNA和蛋白质
来自项目中操纵动物的特定肺血管结构和损伤的研究
1比4。为了支持这一具体目标,我们提出了5项具体任务,其中包括实验计划(任务1)、
组织处理(任务2)、LCM(任务7)以及将形态数据与特定项目目标和
目标(任务8)。
目的4:将特定目的2中的关键表达结果翻译到人类对照和PAH肺。我们
提出六项具体任务以支持具体目标,其中包括实验计划(任务1)、组织
加工(任务2)、人体组织研究(任务3)、形态和体视学(任务4)、激光共聚焦显微镜(任务7)和
将形态数据与具体的项目目标和目的相结合(任务8)。
在实现这些目标方面,最重要的是核心领导层的科学专长。这个
病理和影像核心由鲁宾·M·图德尔博士领导,他是一名实验性和实践性肺
在肺动脉高压的病理学和病理生物学方面具有主要专业知识的病理学家,在
拉菲·涅门诺夫博士,癌症领域经验丰富的研究员,拥有多探针免疫方面的专业知识
以免疫系统和补体为目标的成像。病理学和影像核心的新颖性在于
在独特的资源、无与伦比的专业知识和总体实验广度上,允许整合
以及与所有四个项目相关的人工翻译。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rubin M. Tuder其他文献
A 48-Year-Old Woman With Peripheral Neuropathy, Hypercalcemia, and Pulmonary Infiltrates
- DOI:
10.1378/chest.114.4.1205 - 发表时间:
1998-10-01 - 期刊:
- 影响因子:
- 作者:
Thomas J. Donnelly;Rubin M. Tuder;Thomas R. Vendegna - 通讯作者:
Thomas R. Vendegna
Diagnostic and therapeutic applications of bacteriophage and adeno-associated virus technologies in pulmonary emphysema
- DOI:
10.1016/j.nano.2006.10.082 - 发表时间:
2006-12-01 - 期刊:
- 影响因子:
- 作者:
I. Petrache;W. Arap;R. Pasqualini;T. Flotte;Rubin M. Tuder - 通讯作者:
Rubin M. Tuder
Kolorado Üniversitesi Tip Fakültesi, Tip Bölümü, Translasyonel Akciğer Araştirma Programi, Aurora, Kolorado, ABD;
Kolorado Üniversitesi Tip Fakültesi、Tip Bölümü、Translasyonel Akciğer Araştirma Programi、Aurora、Kolorado、ABD;
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
Rubin M. Tuder;Stephen L. Archer;Peter Dorfmüller;Serpil C. Erzurum;Christophe Guignabert;Evangelos D. Michelakis;Marlene Rabinovitch;Ralph T. Schermuly;Kurt R. Stenmark;NW Morrell - 通讯作者:
NW Morrell
Pulmonary Eosinophilia Following Lung Transplantation for Sarcoidosis in Two Patients
- DOI:
10.1378/chest.123.2.629 - 发表时间:
2003-02-01 - 期刊:
- 影响因子:
- 作者:
Susan G. Gerhardt;Rubin M. Tuder;Reda E. Girgis;Stephen C. Yang;John V. Conte;Jonathan B. Orens - 通讯作者:
Jonathan B. Orens
Hypoxia and chronic lung disease
- DOI:
10.1007/s00109-007-0280-4 - 发表时间:
2007-11-27 - 期刊:
- 影响因子:4.200
- 作者:
Rubin M. Tuder;Jeong H. Yun;Anil Bhunia;Iwona Fijalkowska - 通讯作者:
Iwona Fijalkowska
Rubin M. Tuder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rubin M. Tuder', 18)}}的其他基金
Evaluation of the Dynamic Reciprocity Between Cells and the Vessel Matrix in Pulmonary Hypertension
肺动脉高压细胞与血管基质之间的动态互易性评估
- 批准号:
10224333 - 财政年份:2020
- 资助金额:
$ 17.88万 - 项目类别:
Evaluation of the Dynamic Reciprocity Between Cells and the Vessel Matrix in Pulmonary Hypertension
肺动脉高压细胞与血管基质之间的动态互易性评估
- 批准号:
10470738 - 财政年份:2020
- 资助金额:
$ 17.88万 - 项目类别:
Evaluation of the Dynamic Reciprocity Between Cells and the Vessel Matrix in Pulmonary Hypertension
肺动脉高压细胞与血管基质之间的动态互易性评估
- 批准号:
10686936 - 财政年份:2020
- 资助金额:
$ 17.88万 - 项目类别:
54th Annual Thomas L. Petty Aspen Lung Conference: COPD and Lung Cancer: Common P
第 54 届 Thomas L. Petty Aspen 肺病年度会议:慢性阻塞性肺病和肺癌:常见 P
- 批准号:
8129411 - 财政年份:2011
- 资助金额:
$ 17.88万 - 项目类别:
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
COPD 和肺癌中前列环素-PPARy 轴的共同靶向
- 批准号:
8676740 - 财政年份:2011
- 资助金额:
$ 17.88万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 17.88万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 17.88万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 17.88万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 17.88万 - 项目类别:
Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
- 批准号:
2889694 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 17.88万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)